Rights and permissions
About this article
Cite this article
Rofecoxib: fewer GI adverse events than nonselective NSAIDs. React. Wkly. 927, 5 (2002). https://doi.org/10.2165/00128415-200209270-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200209270-00013